The high degree of APP exon 8 excision in breast tumor versus normal tissue (p<10−5) prompted its inclusion in a 12-marker APP splice variant panel that correctly identified 33 of 35 (96%) of tumor samples in a blinded validation assay. This evidence concerns the gene APP and breast neoplasm.